Oscar Health, Inc. OSCR
We take great care to ensure that the data presented and summarized in this overview for Oscar Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSCR
View all-
Vanguard Group Inc Valley Forge, PA20.2MShares$280 Million0.01% of portfolio
-
Black Rock Inc. New York, NY14.2MShares$197 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.31MShares$115 Million0.1% of portfolio
-
Thrive Capital Management, LLC New York, NY6.34MShares$88 Million47.84% of portfolio
-
American Century Companies Inc Kansas City, MO5.3MShares$73.5 Million0.05% of portfolio
-
State Street Corp Boston, MA5.13MShares$71.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.77MShares$66.2 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$65 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.29MShares$59.5 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.72MShares$51.6 Million0.02% of portfolio
Latest Institutional Activity in OSCR
Top Purchases
Top Sells
About OSCR
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Insider Transactions at OSCR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,149
-2.0%
|
$66,384
$16.59 P/Share
|
|
Dec 02
2025
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,135
-1.83%
|
$402,160
$16.59 P/Share
|
|
Dec 02
2025
|
Janet Liang President, Oscar Insurance |
SELL
Open market or private sale
|
Direct |
7,338
-4.08%
|
$117,408
$16.59 P/Share
|
|
Dec 02
2025
|
Mario Schlosser President of Technology & CTO |
SELL
Open market or private sale
|
Direct |
23,965
-4.78%
|
$383,440
$16.59 P/Share
|
|
Dec 02
2025
|
Adam Mc Ananey Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,852
-1.02%
|
$29,632
$16.59 P/Share
|
|
Nov 12
2025
|
Mario Schlosser President of Technology & CTO |
SELL
Open market or private sale
|
Direct |
105,300
-17.36%
|
$1,579,500
$15.05 P/Share
|
|
Nov 12
2025
|
Mario Schlosser President of Technology & CTO |
BUY
Conversion of derivative security
|
Direct |
105,300
+14.79%
|
-
|
|
Nov 11
2025
|
Mario Schlosser President of Technology & CTO |
SELL
Open market or private sale
|
Direct |
286,182
-36.35%
|
$4,292,730
$15.27 P/Share
|
|
Nov 11
2025
|
Mario Schlosser President of Technology & CTO |
BUY
Conversion of derivative security
|
Direct |
286,182
+26.66%
|
-
|
|
Sep 22
2025
|
Mario Schlosser President of Technology & CTO |
SELL
Open market or private sale
|
Direct |
395,000
-44.08%
|
$7,110,000
$18.43 P/Share
|
|
Sep 22
2025
|
Mario Schlosser President of Technology & CTO |
BUY
Conversion of derivative security
|
Direct |
395,000
+30.59%
|
-
|
|
Sep 02
2025
|
Mario Schlosser President of Technology & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,879
-4.55%
|
$382,064
$16.66 P/Share
|
|
Sep 02
2025
|
Adam Mc Ananey Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,845
-1.01%
|
$29,520
$16.66 P/Share
|
|
Sep 02
2025
|
Janet Liang President, Oscar Insurance |
SELL
Payment of exercise price or tax liability
|
Direct |
7,303
-3.9%
|
$116,848
$16.66 P/Share
|
|
Sep 02
2025
|
Richard Scott Blackley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,166
-2.01%
|
$450,656
$16.66 P/Share
|
|
Sep 02
2025
|
Victoria Baltrus Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,266
-2.93%
|
$100,256
$16.66 P/Share
|
|
Jun 04
2025
|
William Gassen |
BUY
Grant, award, or other acquisition
|
Direct |
14,134
+15.97%
|
-
|
|
Jun 04
2025
|
Vanessa Ames Wittman |
BUY
Grant, award, or other acquisition
|
Direct |
14,134
+9.9%
|
-
|
|
Jun 04
2025
|
Sid Sankaran |
BUY
Grant, award, or other acquisition
|
Direct |
14,134
+50.0%
|
-
|
|
Jun 04
2025
|
David Plouffe |
BUY
Grant, award, or other acquisition
|
Direct |
14,134
+9.9%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 750K shares |
|---|---|
| Exercise of conversion of derivative security | 956K shares |
| Conversion of derivative security | 786K shares |
| Bona fide gift | 296K shares |
| Payment of exercise price or tax liability | 170K shares |
|---|---|
| Open market or private sale | 874K shares |
| Bona fide gift | 296K shares |